Evidence method
Sequential · gp.financial.deposits
-3.69% · CORE · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
SNUS-PH · Mar 31, 2022
Santander Holdings USA, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000811830-22-000025Bank
Evidence method
Level · gp.fundamentals.cash
$13.5B · CORE · VALID
Evidence method
Sequential · gp.financial.loans
-0.29% · CORE · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History65 statesSelf-history eligible
Sep 30, 20216/6 normalizedAmended as filedDec 31, 20215/5 normalizedLevel 3Mar 31, 20223/3 normalizedLevel 3Jun 30, 20226/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20226/6 normalizedLevel 3Mar 31, 20236/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/6 normalizedLevel 3Dec 31, 20236/6 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20245/5 normalizedLevel 3Sep 30, 20245/5 normalizedLevel 3Dec 31, 20245/5 normalizedLevel 3Mar 31, 20255/5 normalizedLevel 3Jun 30, 20255/5 normalizedLevel 3Sep 30, 20255/5 normalizedLevel 3Dec 31, 20255/5 normalizedLevel 3Mar 31, 20265/5 normalizedLevel 3Jun 30, 20264/4 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 2.69%
- Current
- -3.69%
- Delta
- -6.38%
- Previous
- $19.3B
- Current
- $13.5B
- Delta
- -$5.8B
- Previous
- 0.60%
- Current
- -0.29%
- Delta
- -0.88%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.